Understanding Uterine Adenomyoma
At a Glance
Uterine adenomyoma is a usually benign, localized nodule containing endometrial glands, stroma, and smooth muscle. A pathologist confirms it because imaging can resemble a fibroid. Atypical polypoid adenomyoma needs closer follow-up because it can recur and may be linked to endometrial cancer risk.
Receiving a diagnosis of uterine adenomyoma (a localized growth in the uterus) often comes after a long period of uncertainty. Because this condition is rare and frequently confused with more common issues like fibroids, getting a clear answer from a pathology report can feel like a major milestone. Understanding exactly what this lesion is—and what it isn’t—is the first step in navigating your care.
What is a Uterine Adenomyoma?
A uterine adenomyoma is what doctors call a biphasic lesion [1]. This means it is made of two distinct types of tissue that are normally found in different parts of the uterus:
- Endometrial glands and stroma: The tissue that usually lines the inside of your uterus [2].
- Smooth muscle: The thick, muscular tissue that makes up the wall of the uterus [1].
In an adenomyoma, these two tissues are tightly woven together into a solid, localized nodule or “lump.” This structure is what makes it unique compared to other uterine conditions.
How It Differs from Other Conditions
It is very common for an adenomyoma to be mistaken for other things before a final diagnosis is made:
- Uterine Fibroids (Leiomyomas): These are the most common uterine growths. While fibroids are made almost entirely of pure smooth muscle, an adenomyoma must contain those “extra” endometrial glands and stroma [1]. On an ultrasound, they can look nearly identical, but their internal “machinery” is different [3].
- Diffuse Adenomyosis: You may have heard the term “adenomyosis,” which refers to endometrial tissue invading the uterine muscle. Diffuse adenomyosis is widespread throughout the uterine wall [4]. An adenomyoma, by contrast, is a discrete, localized nodule [1]. These entities overlap histologically and clinically but are not interchangeable; many focal lesions are asymptomatic, and evidence that a localized adenomyoma independently causes infertility is limited.
Variants and the “Atypical” Type
Not all adenomyomas are the same. Their behavior depends largely on their specific subtype:
Polypoid Adenomyoma
This version grows into a shape like a “polyp,” often projecting into the cavity of the uterus [5]. These can sometimes cause heavy bleeding because they occupy space where the uterine lining normally sheds [6].
Atypical Polypoid Adenomyoma (APA)
This is a rare and more complex variant [7]. In an APA, the glands inside the nodule appear “atypical” or crowded under a microscope. While still considered a benign (non-cancerous) tumor, APAs require closer monitoring because they have a higher risk of recurring after being removed, and in some cases, they can be associated with a risk of developing endometrial cancer over time [8][7].
Why Diagnosis is Challenging
If you felt like it took a long time to get this diagnosis, you are not alone. There are several scientific reasons why adenomyomas are difficult to identify:
- Imaging Overlap: On a standard ultrasound, an adenomyoma often looks like a common fibroid. Doctors may look for specific clues—like tiny cysts within the nodule or a certain type of blood flow—but these are not always easy to see [9][3].
- Rarity and Data Gaps: Because these are rare, there are no large “population registries” tracking them like there are for cancer. Most of what we know comes from small groups of patients who have already had surgery [8][9]. Because of this rarity, your local doctor may only see a few cases in their entire career.
- The Need for Pathology: A definitive diagnosis usually cannot be made by imaging alone. It requires a pathologist—a doctor who studies tissue under a microscope—to confirm the “biphasic” mix of muscle and glands [10]. Sometimes, specialized tests like p16 or SATB2 staining are used to help distinguish a complex adenomyoma from other conditions [11].
What This Means for You
The most important thing to know is that a diagnosis of a standard uterine adenomyoma is a “benign” finding, meaning it is not cancer [7]. The “diagnostic confusion” you may have experienced is a known hurdle in gynecologic medicine. While the rarity of the condition can be frustrating, the pathology report finally provides the roadmap your medical team needs to discuss the next steps, whether that involves monitoring, hormone therapy, or a procedure to remove the nodule.
If you have been diagnosed with the atypical (APA) variant, your care will likely be more proactive, involving regular check-ups to ensure the lining of your uterus remains healthy [8]. Regardless of the type, your path forward is now based on clear tissue evidence rather than guesswork.
Common questions in this guide
What exactly is a uterine adenomyoma?
How is an adenomyoma different from a fibroid?
Is a uterine adenomyoma cancer?
What does atypical polypoid adenomyoma mean?
How is uterine adenomyoma diagnosed?
What symptoms can a uterine adenomyoma cause?
What are the usual next steps after an adenomyoma diagnosis?
Get notified when new evidence is published on adenomyoma of uterine corpus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Detection of MED12 mutations in mesenchymal components of uterine adenomyomas.
Kito M, Maeda D, Kudo-Asabe Y, et al.
Human pathology 2021; (109()):31-36 doi:10.1016/j.humpath.2020.11.013.
PMID: 33259844 - 2
Adenomyoma With Pseudoinvasive Growth Pattern and Serosal Penetration Mimicking Endometrial Carcinoma.
Raj T, DeWitt R, Smith NE
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2018; (37(4)):397-400 doi:10.1097/PGP.0000000000000421.
PMID: 28700437 - 3
Imaging Diagnosis of Adenomyosis.
O'Shea A, Figueiredo G, Lee SI
Seminars in reproductive medicine 2020; (38(2-03)):119-128 doi:10.1055/s-0040-1719017.
PMID: 33197946 - 4
Junctional zone thickening: an endo-myometrial unit disorder.
Gordts S, Grimbizis G, Tanos V, et al.
Facts, views & vision in ObGyn 2023; (15(4)):309-316 doi:10.52054/FVVO.15.4.109.
PMID: 38128089 - 5
Polypoid Adenomyoma of the Uterus.
Sajjad N, Iqbal H, Khandwala K, Afzal S
Cureus 2019; (11(2)):e4044 doi:10.7759/cureus.4044.
PMID: 31016072 - 6
Multimodal imaging in the diagnosis of uterine polypoid adenomyoma: a case report.
Davis AJ, Gomez E
BJR case reports 2026; (12(4)):uaag029 doi:10.1093/bjrcr/uaag029.
PMID: 42495161 - 7
Surgical treatment of a rare case of atypical polypoid adenomyoma of the uterus in a menopausal patient: a case report.
Thanasa EI, Thanasa AI, Paraoulakis IE, et al.
The Pan African medical journal 2023; (44()):118 doi:10.11604/pamj.2023.44.118.39256.
PMID: 37275297 - 8
Hysteroscopic Transcervical Resection for Atypical Polypoid Adenomyoma of the Uterus: A Valid, Fertility-Preserving Option.
Chiyoda T, Lin BL, Saotome K, et al.
Journal of minimally invasive gynecology 2018; (25(1)):163-169.e1 doi:10.1016/j.jmig.2017.08.659.
PMID: 29038039 - 9
Value of Transabdominal Combined Transvaginal Color Doppler Ultrasonography in the Distinguish between Uterine Adenomyoma and Uterine Fibroids.
Qi H, Zhou C, Huang Z, et al.
BioMed research international 2022; (2022()):9599571 doi:10.1155/2022/9599571.
PMID: 35845931 - 10
A Systematic Review of Tissue Sampling Techniques for the Diagnosis of Adenomyosis.
Movilla P, Morris S, Isaacson K
Journal of minimally invasive gynecology 2020; (27(2)):344-351 doi:10.1016/j.jmig.2019.09.001.
PMID: 31499191 - 11
Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
Worrell HI, Sciallis AP, Skala SL
Histopathology 2021; (79(1)):96-105 doi:10.1111/his.14338.
PMID: 33459390
This page is for informational purposes only and does not constitute medical advice. Your gynecologist and pathologist can explain how your adenomyoma subtype affects monitoring and treatment.